Iran's medicine crisis prices patients out of treatment

Iran is facing a severe medicine crisis, with soaring prices and shortages making it difficult for patients to access treatment. This has led to a situation where a single chemotherapy session can cost six times the monthly minimum wage, a staggering expense for many. As a result, doctors are reporting that more patients are delaying or abandoning treatment they cannot afford, which has significant implications for public health and the economy. The crisis highlights the need for urgent action to address the root causes of the problem and ensure that…

Why it matters

Iran's medicine crisis is causing drug prices to soar and medicine shortages to persist, making treatment unaffordable for many patients. This could lead to a significant increase in mortality rates and a decline in the overall health of the population.

Market impact

Markets & countries in focus

Transmission channels

Likely winners & losers

Explore the intelligence

MeridStreet does not reproduce source articles. The summary and analysis above are generated by MeridStreet from public headlines and its own market model; the original reporting belongs to Deutsche Welle. For information only — not financial advice.